Dare Bioscience, Inc. (DARE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 215.75M |
| Enterprise Value | 193.69M |
| P/E Ratio | -0.9 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 7.79 |
| Price/Book Ratio | -18.87 |
| Enterprise/Revenue | 3.5 |
| Enterprise/EBITDA | -0.56 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -8.04 |
| Operating Margin | -8.13 |
AD
Management Effectiveness
| Return On Assets | -0.49 |
| Return On Equity | -7.48 |
Income Statement
| Revenue | 1.03M |
| Revenue/Share | 0.09 |
| Gross Profit | -1.42M |
| EBITDA | -10.43M |
| Net Income | -13.4M |
| Diluted EPS | -1.2 |
Balance Sheet
| Total Cash | 12.62M |
| Total Cash/Share | 0.85 |
| Total Debt | 6.76M |
| Total Debt/Equity | -12.08 |
| Current Ratio | 0.99 |
| Book Value Per Share | -0.04 |
Price History
| 52-Week Change | -63.4 |
| 52-Week High | 3.78 |
| 52-Week Low | 0.61 |
| Moving Average 50 Days | 0.73 |
| Moving Average 200 Days | 1.54 |
Statistics
| Average Volume | 511,121 |
| Shares Outstanding | 14.98M |
| % Held by Institutions | 8.74 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 01, 2024 |
AD
